A prospective multicenter study investigating rituximab combined with intensive chemotherapy in newly diagnosed pediatric patients with aggressive mature B cell non-Hodgkin lymphoma (CCCG-BNHL-2015): a report from the Chinese Children’s Cancer Group
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00277-022-04904-w.pdf
Reference12 articles.
1. Cairo MS (2019) Rituximab in the treatment of childhood mature B-cell lymphoma: “where do we go from here.” Br J Haematol 185:1017–1020
2. Magrath I, Adde M, Sha A et al (1996) Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J CLinn Oncol 14:925–934
3. Tang JY, Pan C, Chen J et al (2002) Outcome of B-cell non-Hodgkin lymphoma protocol CCCG-B NHL97: a report from Chinese multi-center cooperative group. Med Pediatr Oncol 39:212–214
4. Subspecialty Group of Hematology the Society of Pediatrics Chinese Medical Association; Committee of Pediatrics Chinese Anti-Cancer Association (2014) A collaborative study of children with mature B-cell non-Hodgkin’s lymphoma in China]. [Article in Chinese. Zhonghua Er Ke Za Zhi 52:649–654
5. Woessmann W, Seidemann K, Mann G et al (2005) The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood 105:948–968
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effect of rituximab on immune status in children with aggressive mature B-cell lymphoma/leukemia–a prospective study from CCCG-BNHL-2015;Heliyon;2024-03
2. Burkitt's lymphoma in a young boy progressing to systemic lupus erythematosus during follow-up: a case report and literature review;Frontiers in Pediatrics;2024-03-01
3. A boy diagnosed Burkitt’s lymphoma developed to systemic lupus erythematosus during the follow-up: a case report and literature review;2023-09-04
4. Infectious Complications of Targeted Therapies in Children with Leukemias and Lymphomas;Cancers;2022-10-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3